BFS
MRNA icon

Bare Financial Services’s Moderna MRNA Stock Holding History

Bare Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22K Sell
46
-16
-26% -$828 ﹤0.01% 1006
2026
Q1 		$3.15K Buy
62
+16
+35% +$746 ﹤0.01% 830
2025
Q4 		$1.36K Buy
+46
New +$1.25K ﹤0.01% 1007

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bare Financial Services's MRNA Position: Q2 2026 in Review

Bare Financial Services reduced its Moderna (MRNA) stake by 26% in Q2 2026, selling an estimated $828 and leaving 46 shares worth $3.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

Bare Financial Services first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bare Financial Services held 46 shares of Moderna worth $3.22K as of Q2 2026.
  • Bare Financial Services sold 16 Moderna shares in Q2 2026, an estimated $828.
  • Moderna made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1006 holding.
  • Bare Financial Services first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.